WTO DS642: The Legal Anatomy of the Bharat (India)-China-US Triad

Bureau Report | Legal Compliance | International Trade Law | Washington D.C., USA

WASHINGTON D.C. – The intersection of national industrial policy and international trade law has reached a critical juncture. The U.S. and China have initiated a legal challenge against Bharat (India), centering on whether the Production-Linked Incentive (PLI) schemes constitute “prohibited subsidies” under Articles 3.1(a) and 3.1(b) of the SCM Agreement.

The 126% Tariff: A Legal Precedent?

The U.S. Department of Commerce’s imposition of a 126% duty relies on the legal concept of “Adverse Facts Available” (AFA). For a subsidy to be actionable, the complainant must prove:

1. Financial Contribution: Direct transfer of funds or tax incentives.
2. Benefit: A commercial advantage that would not otherwise be available in the market.
3. Specificity: The subsidy is limited to certain enterprises or industries.

The Defense: Investment vs. Export Subsidies

Bharat (India)’s legal defense hinges on the argument that PLI is an Investment Incentive, not an export subsidy. Unlike the now-defunct MEIS (Merchandise Exports from India Scheme), PLI is based on incremental production and sales, regardless of whether those sales are domestic or international. This distinction is vital for Bharat (India) to survive a WTO panel.

February 2026 – The World Trade Organization (WTO) has officially activated Case DS642: India – Measures Concerning Trade in the Automotive and Renewable Energy Technology Sectors. This is no longer just a trade dispute; it is a test of the WTO’s Agreement on Subsidies and Countervailing Measures (SCM) in a post-globalization era.

1. The Core Legal Contention: SCM Article 3.1(b)

Beijing’s primary legal assault rests on Article 3.1(b) of the SCM Agreement, which prohibits subsidies contingent upon the use of domestic over imported goods. China argues that Bharat (India)’s Production-Linked Incentive (PLI) schemes—specifically for Advanced Chemistry Cell (ACC) batteries and Electric Vehicles—mandate “Domestic Value Addition” (DVA) thresholds that act as de facto local content requirements.

Legal Argument (China): “By conditioning fiscal incentives on a minimum 25% to 50% domestic value addition, Bharat (India) accords ‘less favorable treatment’ to imported Chinese components, violating GATT Article III:4.”

2. Bharat (India)’s Defense: The “Investment Incentive” Doctrine

Bharat (India)’s legal counsel is expected to argue that PLI is a performance-linked investment incentive, not an import-substitution subsidy.

• The Specificity Defense: Bharat (India) maintains that the incentives are available to all enterprises (including global firms like Samsung and Foxconn) provided they manufacture within the territory.
• Article 27 (S&DT): New Delhi will likely invoke “Special and Differential Treatment,” asserting that as a developing economy, it has the sovereign right to use industrial policy to bridge the technological gap in green energy.

3. The U.S. Paradox: Third-Party Ally vs. Adversary

In a fascinating legal twist, the United States has joined DS642 as a third party supporting Bharat (India) against China. Washington’s legal brief criticized Beijing’s move as a diversion from its own “non-market policies.”

However, this support is paradoxical. Simultaneously, the U.S. Department of Commerce has imposed a 126% Countervailing Duty (CVD) on Indian solar imports. This highlights a dual-track strategy: using the WTO to fight China’s influence, while using domestic trade laws (CVDs) to protect the U.S. “Rust Belt” from Bharat (India)’s competitive manufacturing.

🏭 The 14-Sector PLI Data Table: Strategic Outlay 2026

Insert this into all articles to provide the high-authority data expected by readers.

🌍 The “Containment” Perspective

Why Global Powers Want to Stop Bharat (India)’s Growth

The convergence of the U.S. and China against Bharat (India)’s PLI marks a shift toward “Industrial Containment.” * For China: A self-reliant Bharat (India) means the loss of a $100 billion export market.

• For the U.S.: While Bharat (India) is a strategic ally, its rise as a “Green Energy Superpower” threatens the price competitiveness of U.S. domestic manufacturers protected by the Inflation Reduction Act.

By targeting the solar and EV sectors, global powers are attempting to stall Bharat (India) during its most critical phase of industrial transition.

The “Adverse Facts Available” (AFA) Trap

The U.S. Department of Commerce has invoked the AFA methodology following the withdrawal of major Bharat (India) conglomerates from the anti-subsidy probe. Legally, this allows the U.S. to use the “highest possible penalty rate” (126%).

• The SCM Article 3.1 Dispute: The US and China argue that these payments are “contingent on export performance.”
• The Bharat (India) Defense: Counsel will argue under Article 27 of the SCM Agreement, which provides “Special and Differential Treatment” for developing nations, asserting that these are investment-linked incentives aimed at regional development, not market distortion.

Editorial Compliance: Judicial Neutrality

Lawrightstribune.com adheres to the highest standards of legal reporting, providing an objective analysis of treaty interpretations without favoring any sovereign entity.